Lack of transparency of research and development processes are thought to undermine the value of artificial intelligence (AI) and trust in its conclusions. This story highlights concerns generated by AI research examining breast cancer screening. The author discusses how the lack of transparency, while understandable due to proprietary concerns, may reduce the safety of the tools as they are tested for use.